Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PR Newswire —
Company to highlight regulatory progress, clinical trial momentum, and multiple value-driving milestones expected in 2026 DALLAS, Jan. 5, 2026 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies...